PharmaShots | Incisive News in 3 Shots

Subscribe Now

Kintara

Kintara’s VAL-083 Receives the US FDA’s Fast Track Designation for the Treatment of Newly Diagnosed Glioblastoma

Kintara’s VAL-083 Receives the US FDA’s Fast Track Designation for the Treatment of Newly Diagnosed Glioblastoma

June 16, 2022

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us